cleveland clinic glp-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting GLP-1 drugs may be linked

Adults with type 2 diabetes assigned an SGLT2 inhibitor or a GLP-1 receptor agonist during cardiovascular outcomes trials derived benefit from the therapies regardless of whether they were prescribed insulin, according to a meta-analysis.In an analysis of data across eight large, multiyear CV outcomes trials for three classes of diabetes agents, researchers also found that participants using

Explore how GLP-1 receptor agonists may help manage weight regain after bariatric surgery

would have increased access to the widely popular drugs.

Rather, factors are identified that may determine individual incretin secretory responses and explain some of the variations in published findings of group differences in GLP-1 responses to nutrient intake.

Lee nuestro artculo para entender tus opciones.

Hberg par Ausha